The latest quarterly R&D expense is $1.96 Million with a QoQ Growth of -51.02%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $1.96M.
$1.96M
$1.96 Million
Q2 FY2026 · 2026-06-30
-51.02%
vs. $4.01M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $1.96M | -51.02% | -86.86% |
| Q1 FY2026Period end 2026-03-31 | $4.01M | -65.15% | -75.70% |
| Q4 FY2025Period end 2025-12-31 | $11.50M | +12.14% | -30.13% |
| Q3 FY2025Period end 2025-09-30 | $10.26M | -31.34% | -53.40% |
| Q2 FY2025Period end 2025-06-30 | $14.94M | -9.45% | -30.47% |
| Q1 FY2025Period end 2025-03-31 | $16.49M | +0.21% | -3.32% |
| Q4 FY2024Period end 2024-12-31 | $16.46M | -25.21% | +0.96% |
| Q3 FY2024Period end 2024-09-30 | $22.01M | +2.44% | +32.21% |
| Q2 FY2024Period end 2024-06-30 | $21.48M | +25.91% | +13.61% |
| Q1 FY2024Period end 2024-03-31 | $17.06M | +4.65% | +4.76% |
| Q4 FY2023Period end 2023-12-31 | $16.30M | -2.05% | +22.28% |
| Q3 FY2023Period end 2023-09-30 | $16.64M | -11.97% | +16.73% |
| Q2 FY2023Period end 2023-06-30 | $18.91M | +16.10% | +42.84% |
| Q1 FY2023Period end 2023-03-31 | $16.29M | +22.15% | +31.75% |
| Q4 FY2022Period end 2022-12-31 | $13.33M | -6.50% | -11.15% |
| Q3 FY2022Period end 2022-09-30 | $14.26M | +7.73% | +31.50% |
| Q2 FY2022Period end 2022-06-30 | $13.24M | +7.09% | +44.04% |
| Q1 FY2022Period end 2022-03-31 | $12.36M | -17.63% | +34.50% |
| Q4 FY2021Period end 2021-12-31 | $15.01M | +38.38% | N/A |
| Q3 FY2021Period end 2021-09-30 | $10.84M | +18.00% | N/A |
| Q2 FY2021Period end 2021-06-30 | $9.19M | -0.01% | N/A |
| Q1 FY2021Period end 2021-03-31 | $9.19M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
